Literature DB >> 16970762

Cicatricial ectropion: repair with myocutaneous flaps and canthopexy.

Kiran Manku1, James K Leong, Raf Ghabrial.   

Abstract

BACKGROUND: To evaluate the effectiveness of myocutaneous upper eyelid flaps combined with canthopexy to treat cicatricial lower eyelid ectropion.
METHODS: A prospective non-comparative case series undertaken in a private practice setting. Consecutive patients with moderate lower eyelid cicatricial ectropion and upper eyelid dermatochalasis underwent transfer of a bipedicle or monopedicle flap from the upper eyelid combined with canthopexy. The main outcome measures included the occurrence of complications, eyelid position and cosmesis.
RESULTS: Sixty-two consecutive cases of cicatricial ectropion repair using myocutaneous flaps and canthopexy. After a mean follow up of 20 months, 58 (93.5%) of the cases had the lower lid punctum facing posterosuperior into the tear lake, showed lid globe apposition and satisfactory eyelid position. There was mild recurrence of cicatricial ectropion in four patients (6.5%). There were no cases of graft failure or granuloma formation.
CONCLUSION: The use of a myocutaneous flap from the upper eyelid combined with a canthopexy suspension suture for repair of cicatricial ectropion may offer good eyelid position and function. This technique has the advantage of avoiding full thickness blepharotomy and was associated with a low incidence of early recurrence.

Entities:  

Mesh:

Year:  2006        PMID: 16970762     DOI: 10.1111/j.1442-9071.2006.01302.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  2 in total

Review 1.  Eyelid Malposition after Blepharoplasty: An Ounce of Prevention.

Authors:  Katherine J Williams; Richard C Allen
Journal:  Semin Plast Surg       Date:  2021-06-08       Impact factor: 2.314

2.  Vertical-to-Horizontal Rotational Myocutaneous Flap for Repairing Cicatricial Lower Lid Ectropion: A Novel Surgical Technique.

Authors:  Yu-Fan Chang; Chieh-Chih Tsai; Hui-Chuan Kau; Catherine Jui-Ling Liu
Journal:  Biomed Res Int       Date:  2017-10-18       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.